28 March 2025
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 27 March 2025 that a person closely associated with Richard Gray, Non-executive Director of the Company, performed a 'Bed and ISA' transfer of 305 ordinary shares of 0.2p each in the Company ("Ordinary Shares") from their share dealing account to their ISA account on 26 March 2025.
As a result, Richard Gray's total interest in the Company, including all persons closely associated, remains at 7,600 Ordinary Shares, representing 0.011% per cent of the total voting rights of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||
| a) |
Name |
Jennifer Gray |
|||||||||
| 2 |
Reason for the notification |
||||||||||
| a) |
Position/status |
PCA |
|||||||||
| b) |
Initial notification /Amendment |
Initial Notification |
|||||||||
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
| a) |
Name |
CVS Group plc |
|||||||||
| b) |
LEI |
213800J41XDQ2NX48O05 |
|||||||||
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
| a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.2 pence each GB00B2863827 |
|||||||||
| b) |
Nature of the transaction |
On-market purchase |
|||||||||
| c) |
Price(s) and volume(s) |
|
|||||||||
| d) |
Aggregated information - Aggregated volume - Price |
Aggregated volume = 305 Aggregated sale price = £3,071.92 Aggregated purchase price = £3,077.40 |
|||||||||
| e) |
Date of the transaction |
26 March 2025 |
|||||||||
| f) |
Place of the transaction |
London Stock Exchange - AIM (XLON) |
|||||||||